These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6397146)

  • 1. Nursing implications of antithymocyte globulin therapy in organ transplantation.
    Richard AB; Robbins KC; Rovelli MA
    ANNA J; 1984 Aug; 11(5):20-4. PubMed ID: 6397146
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of canine renal allograft survival by using a synthetic progestin in combination with azathioprine and antithymocyte globulin.
    Yellin JA; Enein AA; Goldson H; Hong J; Prince B; Sakai A; Kountz SL
    Surg Forum; 1977; 28():309-11. PubMed ID: 364721
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of sudden deafness probably due to antithymocyte globulin treatment.
    Vural A; Onder T; Tanboğa H
    Nephron; 1995; 69(3):345. PubMed ID: 7753276
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
    Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
    [No Abstract]   [Full Text] [Related]  

  • 7. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
    Alamartine E; Bellakoul R; Berthoux F
    Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithymocyte globulin-induced hemolytic anemia and thrombocytopenia after kidney transplantation.
    de Nattes T; Lelandais L; Etienne I; Laurent C; Guerrot D; Bertrand D
    Immunotherapy; 2018 Jul; 10(9):737-742. PubMed ID: 30008258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Evidence of in situ immune complex formation on the platelet surface.
    Madaio MP; Spiegel JE; Levey AS
    Transplantation; 1988 Mar; 45(3):647-9. PubMed ID: 3279587
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of rabbit antithymocyte serum and pre-transplant transfusion on graft survival.
    Cardella CJ; Pierratos A
    Transplant Proc; 1982 Dec; 14(4):623-6. PubMed ID: 6301116
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there any role for antithymocyte induction in renal transplantation?
    Neidlinger NA; Sollinger HW
    Transplant Proc; 2010 Jun; 42(5):1402-7. PubMed ID: 20620444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of antilymphocyte globulin in renal transplantation.
    Fries D; Hiesse C; Lantz O; Daoud M; Rousseau P; Manseur N; Richalet B; Benoit G; Charpentier B; Eygonnet JP
    Transplant Proc; 1990 Aug; 22(4):1793-4. PubMed ID: 2389452
    [No Abstract]   [Full Text] [Related]  

  • 19. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 20. Histocompatibility-dependent long-term islet of Langerhans survival induced by antithymocyte globulin.
    Beyer MM; Friedman EA
    Transplant Proc; 1979 Jun; 11(2):1436-9. PubMed ID: 112739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.